Navigation Links
Disrupting a destructive duo: U of T Mississauga researchers inhibit cancer proteins
Date:8/20/2009

A research team led by U of T Mississauga scientists has developed a new way to split up a dangerous pair of cancer proteins, a finding that could ultimately lead to chemotherapy that is more effective and has fewer side effects.

Working with scientists at the University of Central Florida and the Princess Margaret Hospital, Professor Patrick Gunning of the Department of Chemical and Physical Sciences has created several molecules that inhibit Stat3, a protein that--in cancer cells--pairs with another copy of itself and goes haywire. The findings appear in the September issue of the journal ChemBioChem: A European Journal of Chemical Biology.

"The molecules we have created are particularly nice because they're showing selectivity against cancer cells but not against healthy cells," says senior author Gunning. "This molecule could be used in conjunction with typical chemotherapeutics, and it could mean that drugs will have less resistanceso you could use lower dosages and cause fewer side effects."

The Stat3 protein is involved in almost all cancers, and is known to contribute to the resistance of cancer cells to current drug therapies. "Most currently available therapeutics aim to induce cell death," says Gunning. "We wanted to make small molecules that could try and stop this protein."

In cancerous cells, Stat3 proteins bind together to work as a lethal pair, and inhibitors work to prevent this. This type of protein-protein interaction is notoriously difficult to counter. Gunning's team targeted binding "hotspots" on a known Stat3 inhibitor called S3I-201. They chemically altered the inhibitor to produce several new variants, which they then tested on Stat3.

In in vitro studies, some variants proved to be even more powerful than S3I-201, and showed activity against prostate, breast and acute myeloid leukemia cancer cell lines. "These are some of the most potent inhibitors in the literature so far for this particular protein," says Gunning. "In some cases, they were more than twice as effective as the existing inhibitor."

When the team used more complex cancer cell models, they found the inhibitors survived the passage across the cell membrane and still targeted the Stat3 cancer proteins inside. Gunning and his colleagues are working to make the new inhibitors even more effective, as well as more metabolically stable, meaning that they can survive the chemical defense mechanisms within the cell.


'/>"/>

Contact: Nicolle Wahl
nicolle.wahl@utoronto.ca
905-569-4656
University of Toronto
Source:Eurekalert

Related biology news :

1. Disrupting common parasites ability to talk to each other reduces infection
2. New genus of self-destructive palm found in Madagascar
3. Researchers boost production of biofuel that could replace gasoline
4. Researchers find genetic link between physical pain and social rejection
5. UTSA biology researchers demystify elusive war zone bacterium
6. UGA researchers propose model for disorders caused by improper transmission of chromosomes
7. Researchers develop new, more-sensitive assay for detecting DNA methylation in colon cancer
8. NIH-funded researchers sequence exomes of 12 people
9. USC researchers identify regulatory genetic sequences that may predict risk for prostate cancer
10. K-State lab gives researchers the tools to study porcine circovirus associated diseases
11. Hebrew U. researchers shed light on the brain mechanism responsible for processing of speech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/20/2017)... ALLENTOWN, Pa. , March 20, 2017 ... PD 2.0 personal spirometer and Wellness Management System (WMS), ... Founded in 2010, PMD Healthcare is a ... Company with a mission dedicated to creating innovative solutions ... of life. With that intent focus, PMD developed the ...
(Date:3/9/2017)... Australia , March 9, 2017 /PRNewswire/ ... at the prestigious World Lung Imaging Workshop at the ... Fouras , was invited to deliver the latest data ... This globally recognised event brings together leaders at the ... latest developments in lung imaging. "The ...
(Date:3/7/2017)... SALT LAKE CITY , March 7, 2017 /PRNewswire/ ... solutions that help top global companies identify the best ... Leonard as Chief Sales Officer (CSO) and ... and Kucer,s appointments round out a seasoned executive team poised ... year and beyond, building on a year of record ...
Breaking Biology News(10 mins):
(Date:3/22/2017)... Maryland (PRWEB) , ... March 21, 2017 , ... ... Life Science Chief Executive Officer Forum on March 23-24 in San Diego. The ... medical device and diagnostic industries. , Benchworks Vice President Christian Meyer will also ...
(Date:3/22/2017)... Washington, USA, and CARDIFF, UK (PRWEB) , ... March 21, 2017 ... ... regional blood flow and tissue oxygenation, is being explored as a way to track ... near-infrared spectroscopy study on tonic pain activation by cold pressor test ,” published today ...
(Date:3/22/2017)... -- Personal Genome Diagnostics Inc. (PGDx) today announced an ... U.S. Department of Veterans Affairs (VA) that replaces ... new CancerSELECT ™ 125 test. CancerSELECT 125 ... that includes microsatellite instability status (MSI), a biomarker ... inhibitor immunotherapies. CancerSELECT 125 will be available to ...
(Date:3/20/2017)... ... March 20, 2017 , ... ... with the ability of endogenous hormones to regulate homeostasis via their cognate ... (antagonists), EDCs produce adverse reproductive, neurological, proliferative, and immunological disorders. EDC exposure ...
Breaking Biology Technology: